Key Market Indicators
Greek Diagnostic Reagent Sales are projected to climb to approximately €22.9 million by 2028, up from €16.1 million in 2023. This represents an annual compound growth rate (CAGR) of 5.6%. Notably, the Greek market experienced a significant 12% year-on-year growth since 2022. In 2023, Greece ranked 12th globally, with Poland surpassing it with the same sales figure of €16.1 million. Spain, the United Kingdom, and Finland occupied the second, third, and fourth positions, respectively. In terms of exports, Greek Diagnostic Reagent Export is expected to reach $15.3 million by 2028, increasing from $13.3 million in 2023. This marks an average annual growth rate of 2.2%. Since 1993, the Greek supply has seen a steady rise of 4.5% per year. In 2023, Greece ranked 38th in the global export market, with Croatia just ahead at $13.3 million. Germany, the Netherlands, and the United Kingdom held the second, third, and fourth spots, respectively. Conversely, Greek Diagnostic Reagent Import is forecasted to see minimal change, reaching approximately $122.3 million by 2028 from $122 million in 2023, indicating a 0% annual growth rate. Since 1993, the demand for diagnostic reagents in Greece has decreased by 1.4% per year.
